HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 -HYDROXYSTEROID DEHYDROGENASE
申请人:Institute Of Medicinal Molecular Design, Inc.
公开号:EP2208728A1
公开(公告)日:2010-07-21
Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor.
A compound represented by the formula:
its pharmaceutically acceptable salt, or a solvate thereof, wherein X is O or S, a broken line and a wavy line represent the presence or the absence of a bond,
(i) when a broken line represents the presence of a bond, a wavy line represents the absence of a bond,
R2 and R3 are each independently hydrogen, halogen, cyano, hydroxy, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl or the like,
(ii) when a broken line represents the absence of a bond, a wavy line represents the presence of a bond,
R1 and R4 are each independently hydrogen, halogen or the like,
R2 and R3 are each independently hydrogen, halogen, cyano, hydroxy, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl or the like, and
R5 and R6 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl or the like.
本发明公开了一种可用作 11β- 羟基类固醇脱氢酶 1 型抑制剂的化合物。
一种由式表示的化合物:
其药学上可接受的盐或其溶液,其中 X 是 O 或 S,折线和波浪线代表键的存在或不存在、
(i) 断线表示有键,波浪线表示无键、
R2 和 R3 各自独立地为氢、卤素、氰基、羟基、羧基、任选取代的烷基、任选取代的烯基、任选取代的炔基或类似物、
(ii) 断线表示无键,波浪线表示有键、
R1 和 R4 各自独立地为氢、卤素或类似物、
R2 和 R3 各自独立地为氢、卤素、氰基、羟基、羧基、任选取代的烷基、任选取代的烯基、任选取代的炔基或类似物,以及
R5 和 R6 各自独立地为氢、任选取代的烷基、任选取代的烯基、任选取代的炔基或类似物。